Care processes and structures associated with higher medication adherence in adolescent and young adult transplant recipients

• Published in: Pediatric transplantation 2021-12, Vol.25 (8), p.e14106-n/a
• Main Authors: Dabirzadeh, Anita, Dahhou, Mourad, Zhang, Xun, Sapir‐Pichhadze, Ruth, Cardinal, Heloise, White, Michel, Johnston, Olwyn, Blydt‐Hansen, Tom D., Tibbles, Lee Anne, Hamiwka, Lorraine, Urschel, Simon, Birk, Patricia, Bissonnette, Janice, Matsuda‐Abedini, Mina, Harrison, Jennifer, Schiff, Jeffrey, Phan, Veronique, De Geest, Sabina, Allen, Upton, Mital, Seema, Foster, Bethany J.
• Format: Article
• Language: English
• Subjects: adolescence; Adolescent; Canada; compliance; Female; Heart transplantation; Humans; Immunosuppressive Agents - administration & dosage; immunosuppressive treatment; Liver transplantation; Male; Medication Adherence; non‐adherence; Patient compliance; Patients; pediatric transplantation; Pediatrics; Prospective Studies; Regression analysis; Surveys and Questionnaires; Teenagers; Transplant Recipients; Young Adult
• ISSN: 1397-3142; 1399-3046
• DOI: 10.1111/petr.14106

Background We aimed to identify care processes and structures that were independently associated with higher medication adherence among young transplant recipients. Methods We conducted a prospective, observational cohort study of 270 prevalent kidney, liver, and heart transplant recipients 14–25 years old. Patients were ≥3 months post‐transplant, ≥2 months post‐discharge, and followed in one of 14 pediatric or 14 adult transplant programs in Canada. Patients were enrolled between June 2015 and March 2018 and followed for 6 months. Adherence was assessed at baseline, 3, and 6 months using the BAASIS© self‐report tool. Patients were classified as adherent if no doses were missed in the prior 4 weeks. Transplant program directors and nurses completed questionnaires regarding care organization and processes. Results Of the 270 participants, 99 were followed in pediatric programs and 171 in adult programs. Median age was 20.3 years, and median time since transplant was 5 years. At baseline, 71.5% were adherent. Multivariable mixed effects logistic regression models with program as a random effect identified two program‐level factors as independently associated with better adherence: minimum number of prescribed blood draws per year for those >3 years post‐transplant (per 1 additional) (OR 1.12 [95% CI 1.00, 1.26]; p = .047), and average time nurses spend with patients in clinic (per 5 additional minutes) (OR 1.15 [1.03, 1.29]; p = .017). Conclusion Program‐level factors including protocols with a greater frequency of routine blood testing and more nurse time with patients were associated with better medication adherence. This suggests that interventions at the program level may support better adherence.